** Shares of AFT Pharmaceuticals AFT.NZ rise as much as
3.3% to NZ$3.10, their highest since April 29
** Stock is on track for its third session of gains, if
trend holds
** Pharmaceutical firm says FY24 operating profit of NZ$24.2
mln ($14.77 mln), up 23%, while full year profit after tax
increases 46% to NZ$15.6 mln
** Declares final dividend of 1.6 NZ cents, higher than 1.1
NZ cents for FY23
** Adds FY25 forecast for operating profit of NZ$22 mln to
NZ$25 mln
** Stock has fallen 14.3% this year, as of last close
($1 = 1.6383 New Zealand dollars)
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.Kumar@thomsonreuters.com;))